# Bimatoprost

## Lumigan PF eye drops 0.03% 0.4mL

| TAH Drug Code      | [ELUMI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ELUMI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Open-angle glaucoma and ocular hypertension. Note: LUMIGAN is indicated for patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure-lowering medications or have insufficient response to them (inability to achieve target intraocular pressure measurements over time), to reduce elevated intraocular pressure.                                                                                                                                                                                                              |
| Dosing             | 1 drop at night in the affected eye, once daily only, as increased dosing may reduce effectiveness. Onset: About 4 hours with peak effect in 8-12 hours. Can be used with other eye meds, spaced 5 minutes apart if multiple.                                                                                                                                                                                                                                                                                                                                                     |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Contraindications  | Hypersensitivity to bimatoprost or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Adverse Effects    | Common: Headache (5%), Blurred vision (1-10%), Conjunctival hemorrhage (1-10%), Conjunctival hyperemia (Elevated intraocular pressure, 27-31% ; hypotrichosis of the eyelashes, <4%), Corneal endothelium finding, Cell loss (5-10%), Dry eye syndrome (Up to 10%), Eye irritation (Up to 10%), Foreign body sensation (5-10%), Iritis (5-10%), Itching of eye (Up to 4%), Pain in eye (1-10%), Photophobia (5-10%), Raised intraocular pressure (5-10%). Serious: Abnormal hair growth, Of the eyelashes (1-4%), Iris color change, Macular retinal edema (1-5%), Uveitis (<1%). |
| Pregnancy          | No (Limited) Human Data â€“ Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/bimatoprost-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

